Literature DB >> 3882760

Characterization and partial purification of a factor from uremic human serum that induces insulin resistance.

M L McCaleb, M S Izzo, D H Lockwood.   

Abstract

We have previously shown that the incubation of normal rat adipose tissue with sera from nondialyzed, nondiabetic uremic patients reduces the transport and metabolism of glucose, in the absence and presence of insulin. In this study insulin-stimulated glucose metabolism by normal rat adipocytes was used as a bioassay to identify the resistance activity, assess the effect of chemical modification on it, and the clinical states associated with its production. The resistance activity was trypsin-labile and had an apparent isoelectric point between 6 and 7, but was not retained by either protein A or concanavalin A columns. The insulin resistance activity was decreased by coincubation with the protein synthesis inhibitor, cycloheximide. Purification to greater than 200,000-fold was attained by heating (100 degrees C) uremic serum, subjecting the supernatant to Sephadex G-25 chromatography and subsequent adsorption to DEAE at pH 7.8 and elution at pH 6.5. The partially purified resistance activity was retained within dialysis tubing of 1,000-mol wt cutoff but not within 2,000-mol wt cutoff. Hemodialysis of patients over 1 wk to 18 mo reduced significantly the amount of resistance activity in their sera. The resistance activity, present in most uremic patients, was not found in the sera of individuals with normal renal function but who were either obese, fasted, elderly or had type II diabetes mellitus. Thus, a circulating small molecular weight peptide, unique to uremia, induced insulin resistance by a protein synthesis-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882760      PMCID: PMC423502          DOI: 10.1172/JCI111712

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Uremic middle molecules exist and are biologically active.

Authors:  J Bergström; P Fürst; L Zimmerman
Journal:  Clin Nephrol       Date:  1979-05       Impact factor: 0.975

Review 2.  Carbohydrate metabolism in uremia: a review.

Authors:  R A DeFronzo; R Andres; P Edgar; W G Walker
Journal:  Medicine (Baltimore)       Date:  1973-09       Impact factor: 1.889

3.  Influence of disease on binding of drugs to plasma proteins.

Authors:  M M Reidenberg; M Affrime
Journal:  Ann N Y Acad Sci       Date:  1973-11-26       Impact factor: 5.691

4.  The alteration of plasma proteins in uremia as reflected in the ability to bind diphenylhydantoin.

Authors:  D W Shoeman; D M Benjamin; D L Azarnoff
Journal:  Ann N Y Acad Sci       Date:  1973-11-26       Impact factor: 5.691

Review 5.  Role of synalbumin insulin antagonist in pathogenesis of diabetes mellitus.

Authors:  M B Davidson; P L Poffenbarger
Journal:  Metabolism       Date:  1970-09       Impact factor: 8.694

6.  Effects of uraemic serum, urea, creatinine and methylguanidine on glucose metabolism.

Authors:  P L Balestri; P Rindi; M Biagini; S Giovannetti
Journal:  Clin Sci       Date:  1972-04       Impact factor: 6.124

7.  Effect of chronic renal failure and hemodialysis on carbohydrate metabolism.

Authors:  C L Hampers; J S Soeldner; P B Doak; J P Merrill
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

8.  Effect of glucocorticoids on the glucose transport system of isolated fat cells.

Authors:  J N Livingston; D H Lockwood
Journal:  J Biol Chem       Date:  1975-11-10       Impact factor: 5.157

9.  Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin.

Authors:  R A DeFronzo; J D Tobin; J W Rowe; R Andres
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

10.  Insulin resistance in uremia. Characterization of lipid metabolism in freshly isolated and primary cultures of hepatocytes from chronic uremic rats.

Authors:  J F Caro; S Lanza-Jacoby
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

View more
  16 in total

Review 1.  The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus.

Authors:  Shazia Hussain; Tahseen A Chowdhury
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

Review 2.  Haemodialysis-induced hypoglycaemia and glycaemic disarrays.

Authors:  Masanori Abe; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2015-04-07       Impact factor: 28.314

Review 3.  Metabolic Abnormalities in Diabetes and Kidney Disease: Role of Uremic Toxins.

Authors:  Laetitia Koppe; Denis Fouque; Christophe O Soulage
Journal:  Curr Diab Rep       Date:  2018-09-08       Impact factor: 4.810

Review 4.  Dietary treatment of renal insufficiency.

Authors:  J T Brocklebank; S Wolfe
Journal:  Arch Dis Child       Date:  1993-12       Impact factor: 3.791

Review 5.  Glycemic control and burnt-out diabetes in ESRD.

Authors:  Csaba P Kovesdy; Jong C Park; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2010-03-30       Impact factor: 3.455

6.  p-Cresyl sulfate promotes insulin resistance associated with CKD.

Authors:  Laetitia Koppe; Nicolas J Pillon; Roxane E Vella; Marine L Croze; Caroline C Pelletier; Stéphane Chambert; Ziad Massy; Griet Glorieux; Raymond Vanholder; Yann Dugenet; Hédi A Soula; Denis Fouque; Christophe O Soulage
Journal:  J Am Soc Nephrol       Date:  2013-01       Impact factor: 10.121

Review 7.  Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon.

Authors:  Jongha Park; Paungpaga Lertdumrongluk; Miklos Z Molnar; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

Review 8.  Updates on the management of diabetes in dialysis patients.

Authors:  Connie M Rhee; Angela M Leung; Csaba P Kovesdy; Katherine E Lynch; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2014-03       Impact factor: 3.455

Review 9.  Carbohydrate metabolism in uremia.

Authors:  R H Mak
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

Review 10.  Insulin and its role in chronic kidney disease.

Authors:  Robert H Mak
Journal:  Pediatr Nephrol       Date:  2007-10-11       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.